EN
HI
Balaxi Pharmaceuticals Chart
Balaxi Pharmaceuticals Share Key Metrics
Volume
17005.00
Market Cap
142.88 CR
LTQ@LTP
10@24.59
ATP
24.79
Var Margin
100 %
Circuit Range
24.59-27.17
Delivery %
0 %
Value
4.22 L
ASM/GSM
No
Market Lot
1
Summary
Balaxi Pharmaceuticals share price is ₹24.59 as of 18 May, 2026. The stock Balaxi Pharmaceuticals intraday movement has stayed between ₹24.59 and ₹25.87, while on a 52-week basis,Balaxi Pharmaceuticals price 52 week high is ₹63.90 & its 52 week low is ₹15.20.
In terms of trading activity, Balaxi Pharmaceuticals has recorded a volume of 17005 shares, The Balaxi Pharmaceuticals has a market cap of ₹55207500 CR. The stock’s Average Traded Price (ATP) stands at ₹24.79, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹24.59.
Balaxi Pharmaceuticals operates within a circuit range of ₹24.59 – ₹27.17, with a Value of ₹4.22 L. The Delivery Percentage for the day is 0%. Additionally, Balaxi Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Balaxi Pharmaceuticals Fundamentals
View MoreP/E Ratio
15.13
P/B Ratio
0.6
Div. Yield
0
Sector P/E
42.2
Sector P/B
2.1
Sec. Div. Yield
79.54
Balaxi Pharmaceuticals Resistance and Support
Pivot 26.22
Resistance
First Resistance
26.91
Second Resistance
27.94
Third Resistance
28.63
Support
First Support
25.19
Second Support
24.5
Third Support
23.47
Balaxi Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-28 | Audited Results & Others |
Balaxi Pharmaceuticals News
BALAXI PHARMACEUTICALS LIMITED
Balaxi Pharma board will convene on May 28, 2026, to approve the audited standalone and consolidated financial results for Q4 and the full fiscal year ended March 31, 2026. This meeting will finalize the company's financial performance for the period.
May 09 2026 19:05:00
BALAXI PHARMACEUTICALS LIMITED
Balaxi Pharmaceuticals board is scheduled to meet on May 28, 2026. The agenda includes considering and approving the audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026.
May 09 2026 19:05:00
Read More
About Balaxi Pharmaceuticals
NSE : 11314
BSE : 0
ISIN : INE618N01022
Balaxi Pharmaceuticals Management
| Name | Position |
|---|---|
| Ashish Maheshwari | Managing Director |
| Minoshi Maheshwari | Promoter & Non-Executive Director |
Balaxi Pharmaceuticals FAQs
The Buying Price of Balaxi Pharmaceuticals share is 24.59 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Balaxi Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Balaxi Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Balaxi Pharmaceuticals shares is 15.13. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Balaxi Pharmaceuticals shares is 0.6. Useful to assess the stock's value relative to its book value.
To assess Balaxi Pharmaceuticals’s valuation compare Sector P/E, P/B which are 42.2 & 2.1 with sector averages, along with growth rates and financial metrics.
The Market Cap of Balaxi Pharmaceuticals is 142.88 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Balaxi Pharmaceuticals share price is 63.90 & 15.20. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Balaxi Pharmaceuticals belongs to the Miscellaneous sector.
